Click Here for

Site Map   Your Account   Support   About Us   Marketplace
Offerings:   Charts   Mobile   Logician   CBSHealthwatch

Medscape Medline Abstract

Link to Online Article (Password Access Only) Order this Document
 Include in Document # 1 of 200 from MEDLINE
selection list. Relevance to Query: 68
Maximum Relevance: 80
Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children.

Am J Respir Crit Care Med 2001 Feb;163(2):429-36   (ISSN: 1073-449X)

Gilliland FD; Li YF; Peters JM [Find other articles with these Authors]
Keck School of Medicine, Department of Preventive Medicine, University of Southern California, Los Angeles, California 90033, USA.

The effects of maternal smoking during pregnancy and childhood environmental tobacco smoke (ETS) exposure on asthma and wheezing were investigated in 5,762 school-aged children residing in 12 Southern California communities. Responses to a self- administered questionnaire completed by parents of 4th, 7th, and 10th grade students were used to ascertain children with wheezing or physician-diagnosed asthma. Lifetime household exposures to tobacco smoke were assessed using responses about past and current smoking histories of household members and any history of maternal smoking during pregnancy. Logistic regression models were fitted to cross-sectional data to estimate the effects of in utero exposure to maternal smoking and previous and current ETS exposure on the prevalence of wheezing and physician-diagnosed asthma. In utero exposure to maternal smoking without subsequent postnatal ETS exposure was associated with increased prevalence of physician-diagnosed asthma (OR, 1.8; 95% CI, 1.1 to 2.9), asthma with current symptoms (OR, 2.3; 95% CI, 1.3 to 4.0), asthma requiring medication use in the previous 12 mo (OR, 2.1; 95% CI, 1.2 to 3.6), lifetime history of wheezing (OR, 1.8; 95% CI, 1.2 to 2.6), current wheezing with colds (OR, 2.1; 95% CI, 1.3 to 3.4) and without colds (OR, 2.5; 95% CI, 1.4 to 4.4), persistent wheezing (OR, 3.1; 95% CI, 1.6 to 6.1), wheezing with exercise (OR, 2.4; 95% CI; 1.3 to 4.3), attacks of wheezing causing shortness of breath (OR, 2.4; 95% CI, 1.3 to 4.4) or awakening at night in the previous 12 mo (OR, 3.2; 95% CI, 1.7 to 5.8), and wheezing requiring medication (OR, 2.1; 95% CI, 1.2 to 3.7) or emergency room visits during the previous year (OR, 3.4; 95% CI, 1.4 to 7.8). In contrast, current and previous ETS exposure was not associated with asthma prevalence, but was consistently associated with subcategories of wheezing. Current ETS exposure was associated with lifetime wheezing (OR, 1.3; 95% CI, 1.1 to 1.5), current wheezing with colds (OR, 1.6; 95% CI, 1.3 to 2.0) and without colds (OR, 1.5; 95% CI, 1.1 to 1.9), wheezing with exercise (OR, 1.7; 95% CI, 1.3 to 2.2), attacks of wheezing causing shortness of breath (OR, 1.6; 95% CI, 1.2 to 2.1) or awakening at night (OR, 1.5; 95% CI, 1.1 to 2.0), and wheezing requiring medication (OR, 1.4; 95% CI, 1.1 to 1.8) or emergency room visits within the previous year (OR, 1.9; 95% CI, 1.2 to 3.0). The effects of current ETS exposure on subcategories of wheezing were most pronounced among children exposed to two or more smokers and remained significant after adjusting for maternal smoking during pregnancy. We conclude that maternal smoking during pregnancy increases the occurrence of physician-diagnosed asthma and wheezing during childhood. In contrast, current ETS exposure is associated with wheezing, but not physician-diagnosed asthma. Taken together, our findings support the hypothesis that ETS operates as a cofactor with other insults such as intercurrent infections as a trigger of wheezing attacks, rather than as a factor that induces asthma, whereas in utero exposure acts to increase physician-diagnosed asthma.

Major Subject Heading(s) Minor Subject Heading(s)
  • Asthma [etiology]
  • Respiratory Sounds [etiology]
  • Smoking [adverse effects]
  • Tobacco Smoke Pollution [adverse effects]

    Find other articles with similar Subjects.

  • Adolescence
  • California
  • Child, Preschool
  • Child
  • Infant, Newborn
  • Infant
  • Pregnancy
  • Risk Factors

  • Indexing Check Tags: Female; Human; Male; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

    Language: English
    MEDLINE Indexing Date: 200103
    Publication Type: Journal Article
    Grant ID: 1R01 HL61768-01; 5P01 ES09581; 5P30 ES07048-02; R826708-01
    PreMedline Identifier: 0011179118
    Unique NLM Identifier: 21109274
    Journal Code: AIM; IM

    Next Next Document
         Go Back To Search Results

    Options for View/Export/Email
    selected references in format. Help
    selected references in format. Help
    selected references in format. Help
    To: Subject:
    Cc: Comments:

    COX-2 Specific Inhibition: How Has It Changed the Lives of Patients and Physicians?
    Site Map   Your Account   Support   About Us   Marketplace

    Medscape Search Options
    Select a database to search, enter a search term, then click “go.”    Advanced Search Forms

    All material on this website is protected by copyright. Copyright © 1994-2001 by Medscape Inc. All rights reserved. This website also contains material copyrighted by 3rd parties. Medscape requires 3.x browsers or better from Netscape or Microsoft.

    Powered by Knowledge Finder® from Aries Systems Corporation